Investigating how retinoic acid signaling affects the development of the fovea in the eye
Role of retinoic acid signaling in fovea development
This study is looking at how a specific signaling process helps form the fovea, the part of the eye that gives us sharp vision, using bird models and human stem cells, with the hope of finding better treatments for eye diseases like age-related macular degeneration.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11012366 on NIH RePORTER |
What this research studies
This research explores the role of retinoic acid signaling in the development of the fovea, a critical part of the retina responsible for sharp vision. By using avian models and human stem cell-derived retinal organoids, the study aims to understand how this signaling pathway influences fovea formation. The researchers will investigate the timing and patterns of retinoic acid signaling during the development process, which could lead to new insights into treating fovea-related diseases. This work is particularly important as current therapies for conditions like age-related macular degeneration are lacking.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for or suffering from age-related macular degeneration or other fovea-related vision disorders.
Not a fit: Patients with non-fovea related vision issues or those without any retinal diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for treating fovea-specific disorders, potentially improving vision for patients with macular degeneration.
How similar studies have performed: While the specific approach of using retinoic acid signaling in fovea development is novel, similar studies in retinal development have shown promising results.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Da Silva, Susana Isabel M M a — University of Pittsburgh at Pittsburgh
- Study coordinator: Da Silva, Susana Isabel M M a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.